CoChat

The Role of Momordica charantia in Resisting Obesity

Open access
Fan, Meiqi, Kim, Eun-Kyung, Choi, Young-Jin, Tang, Yujiao, Moon, Sang-Ho · 2019 · International Journal of Environmental Research and Public Health

The DOI matches its Crossref record; 108 of the 111 references it cites were found in a registry or an index.

Abstract

Momordica charantia (M. charantia), commonly known as bitter gourd, bitter melon, kugua, balsam pear, or karela, is a tropical and sub-tropical vine belonging to the Cucurbitaceae family. It has been used to treat a variety of diseases in the traditional medicine of China, India, and Sri Lanka. Here, we review the anti-obesity effects of various bioactive components of M. charantia established at the cellular and organismal level. We aim to provide links between various bioactive components of M. charantia and their anti-obesity mechanism. An advanced search was conducted on the worldwide accepted scientific databases via electronic search (Google Scholar, Web of Science, ScienceDirect, ACS Publications, PubMed, Wiley Online Library, SciFinder, CNKI) database with the query TS = “Momordica charantia” and “obesity”. Information was also obtained from International Plant Names Index, Chinese Pharmacopoeia, Chinese herbal classic books, online databases, PhD and MSc dissertations, etc. First, studies showing the anti-obesity effects of M. charantia on the cells and on animals were classified. The major bioactive components that showed anti-obesity activities included proteins, triterpenoids, saponins, phenolics, and conjugated linolenic acids. Their mechanisms included inhibition of fat synthesis, promotion of glucose utilization, and stimulation of auxiliary lipid-lowering activity. Finally, we summarized the risks of excessive consumption of M. charantia and the application. Although further research is necessary to explore various issues, this review establishes the therapeutic potential of M. charantia and it is highly promising candidate for the development of anti-obesity health products and medicines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijerph16183251

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Chemical structure of saponins and triterpenes isolated from M. charantia.
Figure 1 Chemical structure of saponins and triterpenes isolated from M. charantia.CC BY · PubMed Central
Figure 2 Chemical structure of phenolics and flavonoids isolated from M. charantia.
Figure 2 Chemical structure of phenolics and flavonoids isolated from M. charantia.CC BY · PubMed Central
Figure 3 Chemical structure of fatty acids isolated from M. charantia.
Figure 3 Chemical structure of fatty acids isolated from M. charantia.CC BY · PubMed Central
Figure 4 Possible mechanisms contributing to the inhibition of fat synthesis and glucose utilization of M. charantia. M. charantia stimulates glucose transporter 4 (GluT-4) to migrate to the cell membrane and mediate glucose uptake by increasing adiponectin, and the adenosine monophosphate-activated protein kinase (AMPK) activity. In addition, M. charantia blocks the expression of PPARγ, and PPARγ downstream pathway including C/EBPα and PI3K to reduce the accumulation of fat.
Figure 4 Possible mechanisms contributing to the inhibition of fat synthesis and glucose utilization of M. charantia. M. charantia stimulates glucose transporter 4 (GluT-4) to migrate to the cell membrane and mediate glucose uptake by increasing adiponectin, and the adenosine monophosphate-activated protein kinase (AMPK) activity. In addition, M. charantia blocks the expression of PPARγ, and PPARγ downstream pathway including C/EBPα and PI3K to reduce the accumulation of fat.CC BY · PubMed Central
Figure 5 Possible mechanisms contributing to the auxiliary lipid-lowering activity of M. charantia. M. charantia reduce the elevated levels of serum cholesterol, phospholipids, triglyceride (TG), and low-density lipoprotein (LDL). On the contrary, M. charantia increases the high-density lipoprotein (HDL) level by elevating lipid flow in the tissues.
Figure 5 Possible mechanisms contributing to the auxiliary lipid-lowering activity of M. charantia. M. charantia reduce the elevated levels of serum cholesterol, phospholipids, triglyceride (TG), and low-density lipoprotein (LDL). On the contrary, M. charantia increases the high-density lipoprotein (HDL) level by elevating lipid flow in the tissues.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 13

  1. Lakholia, 1956, The use of bitter gourd in diabetes mellitus, Antiseptic, 53, 608
  2. Yang, 2013, Research progress on modern pharmacy and hypoglycemic effects of momordicosides, Chin. Tradit. Herb. Drugs, 44, 3582
  3. Zhu, 1990, Study on the Active Ingredients of Momordica charantia L., J. Pharm. Sci., 25, 898
  4. Fenggang, 1995, Studies on the Antifertillty Chemical Constituents of Balsampear (Momordica charantia), Chin. Tradit. Herb. Drugs, 6, 281
  5. Gul, 2013, AMPK: A potent target for treating obesity, Int. J. Pharm. Chem. Bio. Sci., 3, 801
  6. Liu, 2007, Study on HTS Anti-diabetic Antagonists from Momordica charantia L., Food Sci., 28, 313
  7. Zhang, 2006, Processing technology for a bitter gourd granulated solid beverage, Sci. Technol. Food Ind., 27, 108
  8. Ji, 2009, Study on bitter melon health noddle, Sci. Technol. Food Ind., 30, 201
  9. Gao, 2012, Technology of Compound Sausage with Momordica Charantia, Food Ferment., 6, 70
  10. Wang, 2010, Study on processing technology of bitter melon peanut low sugar health drink, Food Nutr. Chin., 6, 57
  11. Zhang, 2006, Development of new type bitter melon yogurt without sugar, Food Sci. Technol., 31, 79
  12. Liu, 2011, Preparation of Solid Beverage of Effervescent Tablet from Bitter Gourd Powder, Food Ind., 2, 31
  13. Zhang, 2005, Technology of compound beverage from bitter gourd and milk, Food Ind., 1, 28

Cited by

See all 65

Metadata

Authors
Fan, M., Kim, E.-K., Choi, Y.-J., Tang, Y., & Moon, S.-H.
Affiliations
  • Konkuk University (KR)
  • Changchun University of Science and Technology (CN)
Corresponding author
Moon, Sang-Ho
Venue
International Journal of Environmental Research and Public Health
Publisher
MDPI AG
Published
2019-09-04
Volume
16
Issue
18
Pages
3251
ISSN
1660-4601 (ISSN-L)
OpenAlex
W2971614026
Cited by
65
References
111
Citations by year
2026: 6 · 2025: 8 · 2024: 8 · 2023: 17 · 2022: 11 · 2021: 12 · 2020: 2
FWCI
0.83
Type
journal article
Language
en
Open access
Locations
  • International Journal of Environmental Research and Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Konkuk University (2018)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Advances in Cucurbitaceae Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Medicinal Plant Research
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Natural Products and Biological Research
Keywords
Momordica charantia, anti-obesity, bioactive compounds, triterpenoids, saponins, phenolic compounds, conjugated linolenic acid, glucose utilization, hypolipidemic activity, traditional medicine
MeSH terms
Animals, Humans, Medicine, Traditional, Obesity, Plant Extracts, Momordica charantia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.